Bryn Mawr Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Bryn Mawr Capital Management's AMGN Position: Q1 2026 in Review
Bryn Mawr Capital Management increased its Amgen (AMGN) stake by 0.08% in Q1 2026, buying an estimated $2.5K and bringing the position to 8,882 shares worth $3.13M. The position accounts for 0.15% of the portfolio, ranked #122.
Bryn Mawr Capital Management first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $5.15M in Q3 2023. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Bryn Mawr Capital Management held 8,882 shares of Amgen worth $3.13M as of Q1 2026.
- Bryn Mawr Capital Management bought 7 Amgen shares in Q1 2026, an estimated $2.5K.
- Amgen made up 0.15% of Bryn Mawr Capital Management's portfolio in Q1 2026, its #122 holding.
- Bryn Mawr Capital Management first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
- Bryn Mawr Capital Management's Amgen position peaked at $5.15M in Q3 2023.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Bryn Mawr Capital Management's 13F filing for Q1 2026, filed 4 May 2026.